Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Blood (2012) 119 (12): 2956–2959.

https://doi.org/10.1182/blood-2011-09-378398

Published: 2012

Includes: Supplemental data

Journal Articles

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

Thomas A. Waldmann, Enrico Lugli, Mario Roederer, Liyanage P. Perera, Jeremy V. Smedley, Rhonda P. Macallister, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Thomas A. Fleisher, H. Clifford Lane, Michael C. Sneller, Roger J. Kurlander, David E. Kleiner, John M. Pletcher, William D. Figg, Jason L. Yovandich, Stephen P. Creekmore

Blood (2011) 117 (18): 4787–4795.

https://doi.org/10.1182/blood-2010-10-311456

Published: 2011

Includes: Supplemental data

Journal Articles

In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation.

S. M. Agnes Yong, MD, PhD, Nicole Stephens, BS, Bipin N. Savani, MD, Yixin Li, PhD, Rhoda Eniafe, BS, Keyvan Keyvanfar, BS, Roger J Kurlander, MD, Katayoun Rezvani, MD, PhD, A. John Barrett, MD

Blood (2009) 114 (22): 192.

https://doi.org/10.1182/blood.V114.22.192.192

Published: 2009

Journal Articles

The Response to Repeated Vaccination with PR1 and WT1 Peptides Admixed in Montanide Adjuvant Is Transient and Fails to Induce Sustained Anti-Leukemia Responses in Patients with Myeloid Malignancies.

Katayoun Rezvani, MD, PhD, Agnes S. M. Yong, MD, PhD, Stephan Mielke, Behnam Jafarpour, Bipin N. Savani, MD, Quan Le, Rhoda Eniafe, BS, Carol Boss, Roger J Kurlander, MD, A. John Barrett, MD

Blood (2009) 114 (22): 4096.

https://doi.org/10.1182/blood.V114.22.4096.4096

Published: 2009

Journal Articles

Prolonging the Incubation of Monocytes with GM-CSF and IL-4 for More Than 3 Days during the Generation of Dendritic Cells (DCS) In Vitro Markedly Diminishes IL-12 and Increases IL-10 Production When DCS Are Subsequently Matured.

Abdul Tawab, PhD, Yong Fan, M.D., Thao Mai, M.T., Elizabeth J. Read, M.D., Roger J. Kurlander, MD

Blood (2006) 108 (11): 3653.

https://doi.org/10.1182/blood.V108.11.3653.3653

Published: 2006

NARROW

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation.

The Response to Repeated Vaccination with PR1 and WT1 Peptides Admixed in Montanide Adjuvant Is Transient and Fails to Induce Sustained Anti-Leukemia Responses in Patients with Myeloid Malignancies.

Prolonging the Incubation of Monocytes with GM-CSF and IL-4 for More Than 3 Days during the Generation of Dendritic Cells (DCS) In Vitro Markedly Diminishes IL-12 and Increases IL-10 Production When DCS Are Subsequently Matured.

Email alerts

ASH Publications

American Society of Hematology

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation.

The Response to Repeated Vaccination with PR1 and WT1 Peptides Admixed in Montanide Adjuvant Is Transient and Fails to Induce Sustained Anti-Leukemia Responses in Patients with Myeloid Malignancies.

Prolonging the Incubation of Monocytes with GM-CSF and IL-4 for More Than 3 Days during the Generation of Dendritic Cells (DCS) In Vitro Markedly Diminishes IL-12 and Increases IL-10 Production When DCS Are Subsequently Matured.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only